Skip to main content
. Author manuscript; available in PMC: 2015 Jul 2.
Published in final edited form as: Cancer Invest. 2010 Nov;28(9):958–962. doi: 10.3109/07357907.2010.483510

Table 1.

Description of the Study Population

Variable Cancer Survivors (n = 168)
Mean ± SD
Healthy Population (n = 170)
Mean ± SD
p value
Age (years) 62.61 ± 11.15 35.84 ± 15.16 .0001
Number of 1st degree relatives 7 ± 3 5 ± 2
N (%) N (%)
Gender
  Males 43 (26) 51 (30)
  Females 124 (74) 119 (70) n.s.
Education
  ≤ High school 73 (43.7) 10 (5.9)
  Some college 48 (28.7) 52 (30.6)
  College graduate 29 (17.4) 66 (38.8)
  Postgraduate 17 (10.2) 42 (24.7) .0001
Ethnicity
  White 166 (99.4) 146 (85.9)
  Other 1 (0.6) 24 (14.1) .0001
Family history of cancer (first degree) 107 (64) 58 (34) .001
Cancer type n/a
  Breast 81(48.5)
  Colon-rectal 20 (12)
  Lymphoma 12 (7.2)
  Lung 9 (5.4)
  Skin 7 (4.1)
  Testicular 4 (2.4)
  Gastro-esophageal 2 (1.2)
  Sarcoma 2 (1.2)
  Othersa 8(4.8)
  Two primaries 20 (12)
  Three primaries 1 (0.6)
  Missing 1 (0.6)
Cleft in family 7 (4.2) 2 (1.2) .07

Note: Totals may vary because of the missing values.

a

Includes one of each of the following: cervix, bladder, endometrial, kidney, oral, ovary, prostate, or eye.